Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Alberca

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Medicina Clinica|January 26, 1991
[Antibodies against hepatitis C virus in hemophiliacs: correlation with peripheral blood lymphocyte populations]E Gómez, I Alberca, V Vicente, et al.
Blood|April 1, 1986
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding timeP M Mannucci, V Vicente, L Vianello, et al.
Anales Espanoles De Pediatria|October 1, 1983
[The pathology of factor VIII in von Recklinghausen's disease: a new association]J Prieto Veiga, J Cedeño Montaño, J De Manueles Jiménez, et al.
Transfusion Medicine (Oxford, England)|September 15, 2009
Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpuraA Julia, L Kovaleva, S Loria, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|February 10, 2015
Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxisF S Lozano, J Sánchez-Fernández, J R González-Porras, et al.
Metabolism: Clinical and Experimental|May 8, 2004
Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic controlJ J Corrales, R M Burgo, B Garca-Berrocal, et al.
Journal of Clinical Laboratory Analysis|April 2, 1999
Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein IC González, A Lestón, B García-Berrocal, et al.
Journal of Thrombosis and Haemostasis : JTH|February 13, 2010
Pharmacogenetics of acenocoumarol in patients with extreme dose requirementsV Pérez-Andreu, V Roldán, M F López-Fernández, et al.
Thrombosis Research|September 29, 2006
Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphismJ R Gonzalez-Porras, F Martin-Herrero, R Garcia-Sanz, et al.
Bone Marrow Transplantation|February 26, 2014
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimusJ Labrador, L López-Corral, O López-Godino, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Medicina Clinica|January 26, 1991
[Antibodies against hepatitis C virus in hemophiliacs: correlation with peripheral blood lymphocyte populations]E Gómez, I Alberca, V Vicente, et al.
Blood|April 1, 1986
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding timeP M Mannucci, V Vicente, L Vianello, et al.
Anales Espanoles De Pediatria|October 1, 1983
[The pathology of factor VIII in von Recklinghausen's disease: a new association]J Prieto Veiga, J Cedeño Montaño, J De Manueles Jiménez, et al.
Transfusion Medicine (Oxford, England)|September 15, 2009
Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpuraA Julia, L Kovaleva, S Loria, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|February 10, 2015
Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxisF S Lozano, J Sánchez-Fernández, J R González-Porras, et al.
Metabolism: Clinical and Experimental|May 8, 2004
Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic controlJ J Corrales, R M Burgo, B Garca-Berrocal, et al.
Journal of Clinical Laboratory Analysis|April 2, 1999
Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein IC González, A Lestón, B García-Berrocal, et al.
Journal of Thrombosis and Haemostasis : JTH|February 13, 2010
Pharmacogenetics of acenocoumarol in patients with extreme dose requirementsV Pérez-Andreu, V Roldán, M F López-Fernández, et al.
Thrombosis Research|September 29, 2006
Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphismJ R Gonzalez-Porras, F Martin-Herrero, R Garcia-Sanz, et al.
Bone Marrow Transplantation|February 26, 2014
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimusJ Labrador, L López-Corral, O López-Godino, et al.
Pageof 8